Article
Correlation of JAK2 V617F mutant allele quantitation with clinical presentation and type of chronic myeloproliferative neoplasm.
Annals of clinical and laboratory science - 1 Jan 2009
Malysz Jozef, Crisan Domnita
Abstract excerpt
Activating JAK2 V617F mutation is present in many patients with chronic myeloproliferative neoplasms. We evaluated, retrospectively, clinical and laboratory data from 70 patients with BCR-ABL1 negative, JAK2 positive, chronic myeloproliferative disease. Quantity of the JAK2 mutant allele was tested for correlation with the clinical presentation, type of chronic myeloproliferative disease, hemoglobin level, white...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.